These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22608587)

  • 41. A recently recognized entity associated with the treatment of acute promyelocytic leukemia: the retinoic acid syndrome.
    Marinakis T; Papadimitriou CA; Koufos C; Fertakis A
    Haematologica; 1993; 78(3):192-4. PubMed ID: 8375752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Retinoic acid syndrome.
    Datta D; Gerardi DA
    Conn Med; 2003 Oct; 67(9):541-3. PubMed ID: 14619342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Acute promyelocytic leukemia (APL) resulting in broad cerebral infarction during all-trans retinoic acid (ATRA) treatment].
    Ikeda Y; Yoshinaga K; Iki S; Ohbayashi Y; Urabe A
    Rinsho Ketsueki; 1994 Feb; 35(2):183-7. PubMed ID: 8139118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].
    Lengfelder E; Simon M; Haase D; Hild F; Hehlmann R
    Dtsch Med Wochenschr; 1994 Aug; 119(34-35):1143-50. PubMed ID: 8076501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. All- trans-retinoic acid-induced erythema nodosum in patients with acute promyelocytic leukemia.
    Kuo MC; Dunn P; Wu JH; Shih LY
    Ann Hematol; 2004 Jun; 83(6):376-80. PubMed ID: 14648024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ATRA-induced myositis in induction therapy of acute promyelocytic leukemia.
    Martínez-Chamorro C; Martínez E; Gil-Fernández JJ; Alonso A; Escudero A; Fernández-Rañada JM
    Haematologica; 2002 Feb; 87(2):ECR08. PubMed ID: 11836177
    [No Abstract]   [Full Text] [Related]  

  • 47. [Very Severe Differentiation Syndrome in Low Risk Acute Promyelocytic Leukemia - A Peril of Differentiating Therapy].
    Hecht A; Mezger J; Gnadler M; Lengfelder E
    Dtsch Med Wochenschr; 2017 Jan; 142(2):111-114. PubMed ID: 28114716
    [No Abstract]   [Full Text] [Related]  

  • 48. Retinoic acid syndrome in NOD/scid mice induced by injecting an acute promyelocytic leukemia cell line.
    Ninomiya M; Kiyoi H; Ito M; Hirose Y; Ito M; Naoe T
    Leukemia; 2004 Mar; 18(3):442-8. PubMed ID: 14749706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The role of cytokines on hyperleukocytosis associated with acute promyelocytic leukemia induced by all-trans retinoic acid therapy].
    Hino K; Nakamaki T
    Rinsho Ketsueki; 1996 Sep; 37(9):770-6. PubMed ID: 8914460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Co-operative study of all-trans retinoic acid as a differentiation induction therapy of acute promyelocytic leukemia].
    Yamada O; Hatake K; Tanimoto M; Ishiyama T; Ohno R; Shirakawa S; Horiuchi A; Tomonaga M; Ohta K
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1981-9. PubMed ID: 8085849
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Acute kidney failure in differentiation syndrome: a possible complication during therapy with differentiating agents for acute promyelocytic leukemia. A case report].
    Di Micco L; Mirenghi F; Morelli E; De Simone E
    G Ital Nefrol; 2019 Jul; 36(4):. PubMed ID: 31373469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulmonary leukostasis secondary to all-trans retinoic acid in the treatment of acute promyelocytic leukemia in first relapse.
    Vosburgh E
    Leukemia; 1992 Jun; 6(6):608-10. PubMed ID: 1602800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pseudotumor cerebri induced by all-trans retinoic acid treatment of acute promyelocytic leukemia.
    Colucciello M
    Arch Ophthalmol; 2003 Jul; 121(7):1064-5. PubMed ID: 12860824
    [No Abstract]   [Full Text] [Related]  

  • 54. Lung injury caused by all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.
    Ariza-Prota M; Pando-Sandoval A; García-Clemente M
    Arch Bronconeumol; 2016 Aug; 52(8):441-2. PubMed ID: 26915524
    [No Abstract]   [Full Text] [Related]  

  • 55. The "retinoic acid syndrome" in acute promyelocytic leukemia.
    Frankel SR; Eardley A; Lauwers G; Weiss M; Warrell RP
    Ann Intern Med; 1992 Aug; 117(4):292-6. PubMed ID: 1637024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Severe side effects of the treatment of acute promyelocytic leukemia with all-trans retinoic acid].
    Han ZP; Lu HB; Shen ZS
    Hunan Yi Ke Da Xue Xue Bao; 2000 Jun; 25(3):283-4. PubMed ID: 12212169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA).
    Klein SK; Biemond BJ; van Oers MH
    Ann Hematol; 2007 Dec; 86(12):917-8. PubMed ID: 17619879
    [No Abstract]   [Full Text] [Related]  

  • 58. Acute neutrophilic dermatosis induced by all-trans-retinoic acid treatment for acute promyelocytic leukemia.
    Levi I; Raanani P; Shalmon B; Schiby-Brilliant R; Ben-Bassat I
    Leuk Lymphoma; 1999 Jul; 34(3-4):401-4. PubMed ID: 10439378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. All-trans retinoic acid-induced myositis.
    Kannan K; Khan HA; Jain R; Hussein SS; Dennison D
    Br J Haematol; 2005 Dec; 131(5):560. PubMed ID: 16351631
    [No Abstract]   [Full Text] [Related]  

  • 60. Retinoic acid syndrome: a case report.
    Tsao HM; Hsu HC
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Nov; 60(5):273-6. PubMed ID: 9509683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.